Intrinsic Value of S&P & Nasdaq Contact Us

Cigna Corporation CI NYSE

NYSE • Healthcare • Medical - Healthcare Plans • US • USD

SharesGrow Score
62/100
4/7 Pass
SharesGrow Intrinsic Value
$810.27
+197.2%
Analyst Price Target
$325.83
+19.5%

Cigna Corporation (CI) — Analyst outlook / Analyst consensus target is. Based on 39 analyst ratings, the consensus is bullish — 1 Strong Buy, 30 Buy, 8 Hold.

The consensus price target is $325.83 (low: $300.00, high: $375.00), representing an upside of 19.5% from the current price $272.60.

Analysts estimate Earnings Per Share (EPS) of $28.51 and revenue of $243.51B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $12.25 vs est $28.51 (missed -57%). 2025: actual $22.30 vs est $29.66 (missed -24.8%). Analyst accuracy: 17%.

CI Stock — 12-Month Price Forecast

$325.83
▲ +19.53% Upside
Average Price Target
Based on 39 Wall Street analysts offering 12-month price targets for Cigna Corporation, the average price target is $325.83, with a high forecast of $375.00, and a low forecast of $300.00.
The average price target represents a +19.53% change from the last price of $272.60.
Highest Price Target
$375.00
Average Price Target
$325.83
Lowest Price Target
$300.00

CI Analyst Ratings

Buy
39
Ratings
31 Buy
8 Hold
Based on 39 analysts giving stock ratings to Cigna Corporation in the past 3 months
Rating breakdown
Strong Buy
1 3%
Buy
30 77%
Hold
8 21%
79%
Buy
31 analysts
21%
Hold
8 analysts
0%
Sell
0 analysts

EPS Estimates — CI

17%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual $12.25 vs Est $28.51 ▼ 132.7% off
2025 Actual $22.30 vs Est $29.66 ▼ 33.0% off
Profitability Outlook
Strong profitability with high earnings per share. EPS trend is improving. Analysts forecast meaningful EPS growth ahead.

Revenue Estimates — CI

99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $244.384B vs Est $243.514B ▲ 0.4% off
2025 Actual $274.952B vs Est $272.260B ▲ 1.0% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message